FR054 is a potent small molecule inhibitor targeting PGM3, a key enzyme in the Hexosamine Biosynthetic Pathway (HBP). It demonstrates significant anti-proliferative and pro-apoptotic effects in breast cancer cell lines, making it a valuable tool for investigating HBPs role in oncology and cancer metabolism research.